DC TB Update

Date: CANCELLED
Location: DC Health & Wellness Center, Training Room, 77 P Street NE, Washington, DC 20002

COURSE DESCRIPTION & OVERALL GOAL
The purpose of this training is to increase providers' awareness and knowledge of TB diagnosis, treatment, and management. Topics will include short course options for treatment of TB infection, conducting large scale contact investigations, application of genotyping in TB prevention and control, updates in pediatric TB, therapeutic drug monitoring, and quality improvements with B1/B2 waivers.

AGENDA

WHO SHOULD ATTEND
This conference is primarily designed for healthcare providers who are involved in the diagnosis, treatment, and management of persons with latent TB infection and disease. The content will be applicable for physicians, physician assistants, nurse practitioners, fellows, and residents. Public health nurses and others working in TB control are welcome to attend.

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

  • State the available regimens for treating TB infection, including completion rates with shorter options.
  • Assess the applicability of WGS for the determination of drug resistance and genotyping/outbreak investigations.
  • Integrate recommendations for prevention and management of TB in children and adolescents.
  • Implement current recommendations to increase treatment completion among patients with Latent TB infection (LTBI). 
  • Outline recommendations for overseas TB medical evaluation and follow-up of B1/B2 immigrants in the United States.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire meeting, and complete an evaluation. A credit letter will be mailed to participants within 2 months of the meeting. Participants will also be asked to complete a follow-up evaluation within this time frame.

  • CONTINUING EDUCATION INFORMATION
    http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the DC Department of Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
    CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    CNE: This activity is awarded 5.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

    DISCLOSURE POLICY
    All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

    REGISTRATION INFORMATION & FEE
    The registration deadline is March 13, 2020. There is no registration fee.

    Conference Registration Page

    We reserve the right to close registration early or cancel late registrants due to limits on seating capacity.

    TRAVEL INFORMATION & DIRECTIONS
    The conference will be held at:
    DC Health & Wellness Center, Training Room
    77 P Street NE
    Washington, DC 20002

    CANCELLATION INFORMATION
    We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

    FUNDING DISCLOSURE
    Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

    If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Olivia Dupont at     od94@njms.rutgers.edu

    . 

    FACULTY

    Debra Benator, MD
    Director, Infectious Disease Clinic
    Washington DC Veterans Affairs Medical Center

    Scott Heysell, MD
    Associate Professor of Infectious Diseases
    University of Virginia

    Jillian Knorr, MPH
    Outbreak Detection and Response Team
    NYC Department of Health and Mental Hygiene Bureau of TB Control

    Mark Wolman, MPH
    Program Manager, TB Control
    Global Tuberculosis Institute

     

    		  

    PLANNING COMMITTEE

    Jason Beverly, MS, RN, FNP-BC
    Supervisor Nurse Practitioner/STD & TB Control Deputy Division Chief
    DC Department of Health

    Jeannette M. Hinnant
    TB Coordinator/Consultant
    DC Department of Health

    Anita Khilall, MPH - Activity Director
    Program Director, Education & Training
    Global Tuberculosis Institute

    Olivia Dupont, MPH
    Health Educator
    Global Tuberculosis Instiute

    Adam Visconti, MD, MPH
    Chief Medical Officer
    DC Department of Health